These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 1478597)

  • 1. [Obstructive respiratory tract diseases--new standards in therapy].
    Ulmer WT
    Fortschr Med; 1992 Nov; 110(32):595-8. PubMed ID: 1478597
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Bronchial hyperreactivity and obstructive respiratory tract diseases. A 2.8 year follow-up study].
    Duchna HW; Hoffarth HP; Ulmer WT
    Fortschr Med; 1994 Jan; 112(3):27-8, 31-2, 35. PubMed ID: 8144122
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The hypersensitive bronchial system. Significance for prognosis inhibition of progression of chronic obstructive respiratory tract diseases].
    Nowak D; Magnussen H
    Internist (Berl); 1993 Apr; 34(4):294-9. PubMed ID: 8486472
    [No Abstract]   [Full Text] [Related]  

  • 4. [Treatment of stable chronic obstructive lung disease with inhaled corticosteroid].
    Vestbo J; Lange P
    Ugeskr Laeger; 2000 Jan; 162(4):520-3. PubMed ID: 10697457
    [No Abstract]   [Full Text] [Related]  

  • 5. [The bronchdilating action of reproterol in patients with bronchial asthma and chronic obstructive bronchitis (author's transl)].
    Tabori D; Conkic B; Todic V; Mijatovic M; Mirkovc S; Zecević D; Camprag D
    Arzneimittelforschung; 1977; 27(12):55-60. PubMed ID: 576833
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Pattern of breathing and obstruction pressure in patients with airway obstruction after inhalation of bronchodilators].
    Franczuk M; Radwan L; Maszczyk Z; Kazimierczak A; Kuś J; Koziorowski A; Kowalski J
    Pneumonol Alergol Pol; 1997; 65(7-8):457-64. PubMed ID: 9410281
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Frequency dependence of compliance in the evaluation of patients with unexplained respiratory symptoms.
    de la Hoz RE; Berger KI; Klugh TT; Friedman-Jiménez G; Goldring RM
    Respir Med; 2000 Mar; 94(3):221-7. PubMed ID: 10783932
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Function analytic control of therapy of obstructive respiratory tract disease].
    Schött D; Micklefield GH; Ulmer WT
    Verh Dtsch Ges Inn Med; 1990; 96():742-5. PubMed ID: 2092516
    [No Abstract]   [Full Text] [Related]  

  • 9. Long-term management of reversible obstructive airways disease in adults.
    Lurie A; Vlastos FD; Dusser DJ; Strauch G; Marsac J
    Lung; 1990; 168 Suppl():154-67. PubMed ID: 1974671
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Asthma therapy: are bronchodilators obsolete?].
    Solèr M
    Schweiz Med Wochenschr; 1992 Mar; 122(13):455-60. PubMed ID: 1348869
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mono- and combination therapy of long-acting bronchodilators and inhaled corticosteroids in advanced COPD.
    Ohar JA; Donohue JF
    Semin Respir Crit Care Med; 2010 Jun; 31(3):321-33. PubMed ID: 20496301
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Short-term treatment with budesonide does not improve hyperresponsiveness to adenosine 5'-monophosphate in COPD.
    Rutgers SR; Koëter GH; van der Mark TW; Postma DS
    Am J Respir Crit Care Med; 1998 Mar; 157(3 Pt 1):880-6. PubMed ID: 9517606
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparison of the action of salbutamol and of isoprenaline on airway resistance in 30 patients with obstructive airways disease.
    Sadoul P; Sentissi M
    Postgrad Med J; 1971 Mar; 47():Suppl:111-2. PubMed ID: 5572508
    [No Abstract]   [Full Text] [Related]  

  • 14. [A strategy of drug treatment of obstructive respiratory tract diseases].
    Slapke J; Adolph J
    Z Arztl Fortbild (Jena); 1989; 83(17):857-9. PubMed ID: 2686213
    [No Abstract]   [Full Text] [Related]  

  • 15. [Does halothane, in subnarcotic dosage, have a detectable broncholytic effect?].
    Gerking A; Ebert C; Precht B; Paliege R; Kirsten D; Pielesch W
    Z Erkr Atmungsorgane; 1986; 166(2):180-5. PubMed ID: 3716494
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Glucocorticoids treatment of exacerbation of chronic obstructive lung diseases].
    Dalsgarth OJ; Vestbo J; Lange P
    Ugeskr Laeger; 2000 Jan; 162(4):529-32. PubMed ID: 10697460
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Use of bronchodilators in the therapy of obstructive respiratory diseases].
    Fortschr Med; 1983 Mar; 101(10):435-6. PubMed ID: 6840647
    [No Abstract]   [Full Text] [Related]  

  • 18. Comparative effects of a fixed combination of reproterol hydrochloride and disodium cromoglycate with each agent alone on antigen-induced airway responses in sheep.
    Abraham WM; Sabater JR; Szelenyi S; Bähre M
    Pulm Pharmacol Ther; 1998; 11(4):271-6. PubMed ID: 10101743
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Comparison of bronchodilator effects and site of action of fenoterol and ipratropium in chronic obstructive bronchitis].
    Kheir A; Ying Y; Hannhart B; Duvivier C; Peslin R; Polu JM
    Rev Mal Respir; 1993; 10(1):9-15. PubMed ID: 8451502
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Corticosteroids].
    Löfdahl CG
    Rev Mal Respir; 1998 Sep; 15 Suppl 2():S42-4. PubMed ID: 9809343
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.